Literature DB >> 12767514

pH effects on the cellular uptake of four photosensitizing drugs evaluated for use in photodynamic therapy of cancer.

Eva G Friberg1, Beata Cunderlíková, Erik O Pettersen, Johan Moan.   

Abstract

The difference in extracellular pH in malignant as compared to normal healthy tissues has been proposed to contribute to selective uptake of photosensitizers in tumors. Hematoporphyrin IX (HpIX), disulfonated meso-tetraphenylporphine (TPPS(2a)), meso-tetra(3-hydroxyphenyl)porphine (mTHPP) and meso-tetra(3-hydroxyphenyl)chlorin (mTHPC) were chosen to examine the pH dependence of their cellular drug uptake. The study was performed in the pH range 6.5-8.0 and showed that significantly higher amounts of the drug are taken up by T-47D cells at low pH values only in the case of HpIX. The pH value of the incubation medium did not influence the cellular uptake of mTHPP, mTHPC and TPPS(2a) significantly. The present work indicates that tumor selectivity of dyes, which get more lipophilic with decreasing pH value, may be related to the low extracellular pH value.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767514     DOI: 10.1016/s0304-3835(03)00150-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

Review 1.  Drug resistance and cellular adaptation to tumor acidic pH microenvironment.

Authors:  Jonathan W Wojtkowiak; Daniel Verduzco; Karla J Schramm; Robert J Gillies
Journal:  Mol Pharm       Date:  2011-10-26       Impact factor: 4.939

2.  pH effect on cellular uptake of Sn(IV) chlorine e6 dichloride trisodium salt by cancer cells in vitro.

Authors:  Khaled A Al-Khaza'leh; Khalid Omar; M S Jaafar
Journal:  J Biol Phys       Date:  2010-10-30       Impact factor: 1.365

3.  In Vitro Assessment of Binding Affinity, Selectivity, Uptake, Intracellular Degradation, and Toxicity of Nanobody-Photosensitizer Conjugates.

Authors:  Irati Beltrán Hernández; Timo W M De Groof; Raimond Heukers; Sabrina Oliveira
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Breast cancer as photodynamic therapy target: Enhanced therapeutic efficiency by overview of tumor complexity.

Authors:  María Julia Lamberti; Natalia Belén Rumie Vittar; Viviana Alicia Rivarola
Journal:  World J Clin Oncol       Date:  2014-12-10

5.  Efficient synthesis and photodynamic activity of porphyrin-saccharide conjugates: targeting and incapacitating cancer cells.

Authors:  Xin Chen; Li Hui; David A Foster; Charles Michael Drain
Journal:  Biochemistry       Date:  2004-08-31       Impact factor: 3.162

Review 6.  Fluorescence-guided surgery for brain tumors.

Authors:  Martin Hefti
Journal:  CNS Oncol       Date:  2013-01

7.  In vitro studies on erythrosine-based photodynamic therapy of malignant and pre-malignant oral epithelial cells.

Authors:  Abhishek D Garg; Muthiah Bose; Mohammed I Ahmed; William A Bonass; Simon R Wood
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

8.  Could clinical photochemical internalisation be optimised to avoid neuronal toxicity?

Authors:  Caitriona O'Rourke; Colin Hopper; Alexander J MacRobert; James B Phillips; Josephine H Woodhams
Journal:  Int J Pharm       Date:  2017-06-01       Impact factor: 5.875

9.  PEGylated Purpurin 18 with Improved Solubility: Potent Compounds for Photodynamic Therapy of Cancer.

Authors:  Vladimíra Pavlíčková; Silvie Rimpelová; Michal Jurášek; Kamil Záruba; Jan Fähnrich; Ivana Křížová; Jiří Bejček; Zdeňka Rottnerová; Vojtěch Spiwok; Pavel Drašar; Tomáš Ruml
Journal:  Molecules       Date:  2019-12-06       Impact factor: 4.411

10.  Endolysosomal targeting of a clinical chlorin photosensitiser for light-triggered delivery of nano-sized medicines.

Authors:  Elnaz Yaghini; Ruggero Dondi; Kunal M Tewari; Marilena Loizidou; Ian M Eggleston; Alexander J MacRobert
Journal:  Sci Rep       Date:  2017-07-20       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.